Avid Bioservices, Inc. (CDMO)
Feb 5, 2025 - CDMO was delisted (reason: acquired by GHO & Ampersand)
12.49
0.00 (0.00%)
Inactive · Last trade price
on Feb 4, 2025
Avid Bioservices Analyst Ratings
Total Analysts
3
Consensus Rating
Hold
Price Target
$12.25
Upside
-1.92%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy → Hold Downgrades $12 → $13 | Buy → Hold | Downgrades | $12 → $13 | +0.08% | Nov 7, 2024 |
| William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 7, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $8 → $12 | Buy | Maintains | $8 → $12 | -3.92% | Sep 10, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $12 | Buy | Reiterates | $12 | -3.92% | Sep 10, 2024 |
| William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 10, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $8 | Buy | Reiterates | $8 | -35.95% | Jul 3, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | -35.95% | Apr 30, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $15 → $12 | Buy | Maintains | $15 → $12 | -3.92% | Mar 11, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $7 | Buy | Reiterates | $7 | -43.96% | Mar 7, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $15 → $7 | Buy | Maintains | $15 → $7 | -43.96% | Dec 8, 2023 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $22 → $16 | Strong Buy | Maintains | $22 → $16 | +28.10% | Dec 8, 2023 |
| Keybanc | Keybanc | Buy Maintains $20 → $14 | Buy | Maintains | $20 → $14 | +12.09% | Dec 8, 2023 |
| William Blair | William Blair | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 28, 2023 |
| RBC Capital | RBC Capital | Buy Maintains $17 → $15 | Buy | Maintains | $17 → $15 | +20.10% | Sep 8, 2023 |
| RBC Capital | RBC Capital | Buy Maintains $20 → $17 | Buy | Maintains | $20 → $17 | +36.11% | Jun 22, 2023 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $24 | Buy | Reiterates | $24 | +92.15% | Jun 22, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.